The Vice Dean for Clinical Science Research is a new leadership role accountable for successfully implementing the research strategic plan as it pertains to clinical science within the overall BSD/PSOM research mission.
Himelhoch comes to UChicago from the University of Kentucky, where his public health research has focused on interventions for those with HIV and substance use disorders and cancer control.
Four UChicago Medicine faculty members were elected to the 2024 class of the Association of American Physicians (AAP), a prestigious medical society that acknowledges the nation's leading physician-scientists.
Savage succeeds Bana Jabri, who has chaired the committee since July 2020.
A 'Comprehensive Cancer Center' is the top U.S. designation for cancer research and treatment facilities recognized by high-quality research that leads to major shifts in cancer care.
In an anniversary event, the collaborative between UChicago Medicine and Advocate Health Care explored the success of community work and local partnerships.
Researchers from the University of Chicago had a paper published in JAMA that dug into data on why so few mental health and substance use facilities opted not to use long-acting injectable buprenorphine to help people with opioid use disorder.
Resmetirom (Rezdiffra) is the first drug approved for treating MASH, an advanced form of fatty liver disease. UChicago Medicine experts contributed to a recent clinical trial and will begin incorporating the drug into liver disease treatment regimens for eligible patients.
UChicago Medicine plans to build a new clinical lab facility in Washington Park that would consolidate existing clinical labs, modernize operations, create new jobs and support educational pathways for in-demand healthcare careers.
Expected to open April 29, UChicago Medicine Crown Point will be the organization's first freestanding facility in Indiana — and its largest offsite location. Patients can make appointments starting March 18.
Two new studies from the University of Chicago investigate the roles of the gut microbiome and estrogen in the differing rates of Alzheimer’s disease among women and men.
The University of Chicago Medicine expanded its neuroscience expertise in China via collaborations with Shanghai Blue Cross Brain Hospital to support improved healthcare delivery, clinical quality and operational efficiency worldwide.
Neuroscientist Emily Rogalski, PhD, is a principal investigator on a grant from the NIH to support a clinical trial of a telehealth intervention for primary progressive aphasia (PPA).
A new center at the University of Chicago Medicine will provide strategic leadership to bring together researchers, healthcare providers and community members to eliminate Chicago’s chronic cancer disparities.
Urogynecology and women’s health care now available; gastrointestinal services to be added this spring.
UChicago Medicine researchers led the development of a new risk score for prioritizing heart transplant candidates based on medical urgency, incorporating objective clinical measurements to offer a more precise and fair alternative to the current system.
UChicago Medicine was the first hospital in Illinois to treat patients using histotripsy, a new noninvasive technology that uses ultrasound energy to precisely destroy liver tumors.
Storb was a Professor in the Department of Molecular Genetics and Cell Biology for more than 29 years.
As AD for Basic Sciences, Macleod will have oversight of basic research activities across the Center and oversee research program infrastructure.
A new study led by UChicago researchers found that changes in male gender expression from adolescence to young adulthood align closely with the gender norms present in individuals’ school environments, and that these trajectories are associated with subsequent patterns of substance abuse.
A seasoned healthcare leader, Kimyatta Washington brings to UChicago Medicine more than 15 years of experience in cancer services.
Researchers at UChicago were able to predict postoperative infections in liver transplant patients by analyzing molecules in their poop — a key leap forward in exploring the connection between the gut microbiome and overall health.
UChicago Medicine Comer Children’s Hospital will be among the first in the country to offer gene therapy for sickle cell disease after regulators approved two new treatments.
UChicago Medicine researchers discover that restoring BAMBI to normal levels in immune suppressive cells can overcome resistance to radiation therapy.
A new paper addresses the use of algorithms in healthcare, their impact on racial/ethnic disparities in care, and approaches to identify and mitigate biases.
Susan and Tandean Rustandy are donating $20 million to UChicago Medicine to advance cancer discoveries and care-delivery innovation at its state-of-the-art cancer care and research facility, the first of its kind in Illinois.
The academic health system opened a primary care location that includes family medicine physicians and general pediatricians, along with a second primary care location that will offer senior care in 2024.
The academic medical center is one of only 74 "Top Teaching Hospitals" on the 2023 list, which highlights nationally recognized achievements in patient safety and quality.
Scientists at UChicago discover that trans-vaccenic acid (TVA), a fatty acid found in beef, lamb, and dairy products, improves the ability of immune cells to fight tumors.
Located in the hospital's neonatal intensive care unit, the new Small Baby Unit is designed to care for babies who fall under certain age and weight specifications.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right